Source: Virtual Congress 2021 – Novel insights into the diagnosis, mechanism and treatment of malignant pleural disease



Rating:

Share or cite this content

Citations should be made in the following way:
E. Janssens (Wilrijk, Belgium), Z. Mol (Ghent, Belgium), L. Vandermeersch (Ghent, Belgium), C. Walgraeve (Ghent, Belgium), J. Van Meerbeeck (Edegem, Belgium), E. Marcq (Wilrijk, Belgium), K. Lamote (Wilrijk, Belgium). In vitro discrimination between mesothelioma and lung cancer based on headspace volatile profiling. 1515

Member's Comments

No comment yet.

Related content which might interest you: Refining the breath fingerprint of mesothelioma patients by in vitro identification of cancer cell line-specific volatile metabolites Source: International Congress 2017 – Pleural and mediastinal malignancies Year: 2017 A step towards easier diagnosis of lung cancer: Detection of volatile organic compounds in air releasing tumour samples with ion- and differential mobility spectrometry Source: Annual Congress 2011 - Innovative diagnostic methods for lung cancer Year: 2011 VOC analysis in headspace air of mesothelioma and lung cancer cell lines: A comparative literature study Source: International Congress 2016 – Mesothelioma and malignant pleural disease Year: 2016 Novel non invasive early detection of lung cancer using liquid immunobiopsy metabolic activity profiles. Source: International Congress 2018 – Lung cancer: from early diagnosis to modern monitoring strategies Year: 2018 Volatile organic compounds (VOC) in non-small-cell lung cancer (NSCLC) Source: Annual Congress 2010 - The role of biomarkers in lung cancer Year: 2010 Identification of predictive biomarkers of immunotherapy response in non-small cell lung cancer by multiparametric analysis Source: Virtual Congress 2021 – New clinical and biological developments in lung cancer Year: 2021 Gene expression profiling reveal novel biomarkers in non-small cell lung cancer Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in non-neoplastic and neoplastic lung diseases Year: 2010 Volatile organic compounds in lung cancer patients before and after tumour resection Source: Annual Congress 2011 - Biomarkers and other new methods for lung cancer Year: 2011 Molecular signatures of non-small cell lung cancer (NSCLC) obtained from gene expression profiling of the benign bronchial mucosa of smokers with and without NSCLC Source: Annual Congress 2013 –Biology and molecular pathology of lung cancer Year: 2013 Early detection of lung cancer through analysis of VOC biomarkers in exhaled breath: The LuCID study. Source: International Congress 2017 – Lung cancer: clinical research on exhaled breath, clinical trials in advanced NSCLC and real-life appraisals of immunotherapies Year: 2017 Multi-omic molecular profiling of lung cancer in COPD Source: Eur Respir J, 52 (1) 1702665; 10.1183/13993003.02665-2017 Year: 2018 Expression profiling in hypoxic non-small cell lung cancer explants reveals a four-gene hypoxia signature Source: Annual Congress 2011 - Lung cancer: molecular pathology and functional genomics Year: 2011 High sensitivity of PD-L1 analysis from pleural effusion in nonsmall cell lung cancer Source: ERJ Open Res, 7 (1) 00787-2020; 10.1183/23120541.00787-2020 Year: 2021 PD-L1 determination in cytological and histological samples in patients with non-small cell lung cancer Source: International Congress 2018 – Linear and radial EBUS and peripheral nodules Year: 2018 Liquid biopsy for EGFR mutations in non-small cell lung cancer cases by RT-PCR Source: International Congress 2018 – Lung cancer: from early diagnosis to modern monitoring strategies Year: 2018 Current and future applications of liquid biopsy in nonsmall cell lung cancer from early to advanced stages Source: Eur Respir Rev, 29 (155) 190052; 10.1183/16000617.0052-2019 Year: 2020 Comparing exhaled molecular profiles of patients with non-small cell lung cancer (NSCLC) with those of patients with non-pulmonary malignancy Source: Annual Congress 2010 - Exhaled biomarkers: smells like disease Year: 2010 LSC Abstract – Transcriptomic profiling of macrophages isolated from human non-small cell lung carcinoma (NSCLC) reveals novel macrophage subsets with distinct tumour response features Source: International Congress 2016 – Lung cancer immunology: latest research Year: 2016 Influence of overexpression of coagulantic and fibrolytic components in tumor tissues on the prognosis of non-small cell lung cancer Source: Annual Congress 2007 - Diagnosis and prognosis in thoracic oncology Year: 2007 Validation of the prognostic value of growth pattern classification in operated non-small cell lung cancer (NSCLC) Source: Annual Congress 2010 - Actual challenges in thoracic surgery Year: 2010